Abstract
These experiments investigated the involvement of gonadotrope progesterone receptor (PR) in the effects of the putative gonadotropin surge-attenuating factor (GnSAF) on gonadotropin (LH and FSH) secretion. Human follicular fluids (hFF) used in this study were aspirated from follicles in gonadotropin-treated women for in vitro fertilization. Samples were subjected to two-fold charcoal extraction of steroid hormones and two-fold inhibin immunoprecipitation. Gonadotropin secretion parameters were assessed by specific radioimmunoassays. In the first experiment, the effects of hFF on both basal and GnRH-stimulated gonadotropin secretion and GnRH self-priming were studied in incubated hemipituitaries from rats on each day of the 4-day estrous cycle. hFF inhibited only GnRH self-priming in pituitaries from rats in diestrus. In the second experiment, immunohistochemical PR expression and action were evaluated in pituitaries from rats in diestrus. PR-positive (PR10A9 antibody) gonadotropes were detected (4–5/field 40x), and antiprogestins added to the incubation media blocked the ligand-independent (GnRH) activation of PR effects on GnRH self-priming. Finally, the third experiment evaluated the effects of hFF on P-induced potentiation of GnRH-stimulated LH secretion. GnSAF bioactivity, as evidenced by inhibition of PR-induced potentiation of GnRH-stimulated LH secretion, was found in diestrous pituitaries incubated with hFF. The results indicate that GnSAF attenuated GnRH-dependent LH secretion in diestrus through the inhibition of PR-dependent GnRH self-priming.
Similar content being viewed by others
References
Koppenaal DW, Tijssen AM, van Dieten JA, de Koning J. The self-priming action of LHRH is under negative FSH control through a factor released by the ovary: observations in female rats in vivo. J Endocrinol 1991, 129: 205–11.
Danforth DR, Cheng CY. Purification of a candidate gonadotropin surge inhibiting factor from porcine follicular fluid. Endocrinology 1995, 136: 1658–65.
Fowler PA, Templeton A. The nature and function of putative gonadotropin surge-attenuating/inhibiting factor (GnSAF/IF). Endocr Rev 1996, 17: 103–20.
Fowler PA, Sorsa-Leslie T, Harris W, Mason HD. Ovarian gonadotrophin surge-attenuating factor (GnSAF): where are we after 20 years of research? Reproduction 2003, 126: 689–99.
Whitehead SA. A gonadotrophin surge attenuating factor? J Endocrinol 1990, 126: 1–4.
Balen AH, Jacobs HS. Gonadotrophin surge attenuating factor: A missing link in the control of LH secretion? Clin Endocrinol (Oxf) 1991, 35: 399–402.
Balen AH. Gonadotrophin surge attenuating factor: where are we now? Clin Endocrinol (Oxf) 1996, 44: 177–80.
Pappa A, Seferiadis K, Fotsis T, et al. Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid. Hum Reprod 1999, 14: 1449–56.
de Koning J, Lambalk CB, Helmerhorst FM, Helder MN. Is GNRH self-priming an obligatory feature of the reproductive cycle? Hum Reprod 2001, 16: 209–14.
Fowler PA, Spears N. The cultured rodent follicle as a model for investigations of gonadotrophin surge-attenuating factor (GnSAF) production. Reproduction 2004, 127: 679–88.
Tavoulari S, Frillingos S, Karatza P, Messinis IE, Seferiadis K. The recombinant subdomain IIIB of human serum albumin displays activity of gonadotrophin surge-attenuating factor. Hum Reprod 2004, 19: 849–58.
Karligiotou E, Kollia P, Kallitsaris A, Messinis IE. Expression of human serum albumin (HSA) mRNA in human granulosa cells: Potential correlation of the 95 amino acid long carboxyl terminal of HSA to gonadotrophin surge-attenuating factor. Hum Reprod 2006, 21: 645–50.
Busbridge NJ, Chamberlain GV, Griffiths A, Whitehead SA. Non-steroidal follicular factors attenuate the self-priming action of gonadotropin-releasing hormone on the pituitary gonadotroph. Neuroendocrinology 1990, 51: 493–9.
Byrne B, Fowler PA, Fraser M, Culler MD, Templeton A. Gonadotropin surge-attenuating factor bioactivity in serum from superovulated women is not blocked by inhibin antibody. Biol Reprod 1995, 52: 88–95.
Byrne B, Fowler PA, Templeton A. Role of progesterone and nonsteroidal ovarian factors in regulating gonadotropin-releasing hormone self-priming in vitro. J Clin Endocrinol Metab 1996, 81: 1454–9.
Geiger JM, Plas-Roser S, Aron C. Mechanisms of ovulation in female rats treated with FSH at the beginning of the estrous cycle: Changes in pituitary responsiveness to luteinizing hormone releasing hormone (LHRH). Biol Reprod 1980, 22: 837–45.
de Koning J, Tijssen AM, van Rees GP. The involvement of ovarian factors in maintaining the pituitary glands of female rats in a state of low LH responsiveness to LHRH. J Endocrinol 1987, 112: 265–73.
Gordon A, Garrido-Gracia JC, Aguilar R, et al. The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not pr expression. J Endocrinol 2008, 196: 583–92.
Gordon A, Garrido-Gracia JC, Aguilar R, et al. Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat. Reproduction 2009, 137: 151–9.
Watanabe G, Taya K, Sasamoto S. Dynamics of ovarian inhibin secretion during the oestrous cycle of the rat. J Endocrinol 1990, 126: 151–7.
Woodruff TK, Mayo KE. Regulation of inhibin synthesis in the rat ovary. Annu Rev Physiol 1990, 52: 807–21.
Arai K, Watanabe G, Taya K, Sasamoto S. Roles of inhibin and estradiol in the regulation of follicle-stimulating hormone and luteinizing hormone secretion during the estrous cycle of the rat. Biol Reprod 1996, 55: 127–33.
Farnworth PG, Robertson DM, de Kretser DM, Burger HG. Effects of 31 kDa bovine inhibin on FSH and LH in rat pituitary cells in vitro: antagonism of gonadotrophin-releasing hormone agonists. J Endocrinol 1988, 119: 233–41.
Culler MD. In vivo evidence that inhibin is a gonadotropin surge-inhibiting/attenuating factor. Endocrinology 1992, 131: 1556–8.
Tio S, van Dieten JA, de Koning J. Immunoneutralization of follicle stimulating hormone does not affect gonadotrophin surge-inhibiting factor/attenuating factor bioactivity during the rat ovarian cycle. Hum Reprod 1998, 13: 2731–7.
Tebar M, Ruiz A, Bellido C, Sanchez-Criado JE. Ovary mediates the effects of RU486 given during proestrus on the diestrous secretion of luteinizing hormone in the rat. Biol Reprod 1996, 54: 1266–70.
Tebar M, Ruiz A, Sanchez-Criado JE. Involvement of estrogen and follicle-stimulating hormone on basal and luteinizing hormone (LH)-releasing hormone-stimulated LH secretion in RU-486-induced 3-day estrous cycle in the rat. Biol Reprod 1998, 58: 615–9.
Fowler PA, Sorsa-Leslie T, Cash P, et al. A 60–66 kDa protein with gonadotrophin surge attenuating factor bioactivity is produced by human ovarian granulosa cells. Mol Hum Reprod 2002, 8: 823–32.
Hamada T, Watanabe G, Kokuho T, et al. Radioimmunoassay of inhibin in various mammals. J Endocrinol 1989, 122: 697–704.
Sánchez-Criado JE, Bellido C, Galiot F, López FJ, Gaytán F. A possible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat. Biol Reprod 1990, 42: 877–86.
Greenwood FC, Hunter WM, Glover JS. The preparation of 1–131-labelled human growth hormone of high specific radioactivity. Biochem J 1963, 89: 114–23.
Kastner P, Krust A, Turcotte B, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms a and b. EMBO J 1990, 9: 1603–14.
Sanchez-Criado JE, Martin De Las Mulas J, Bellido C, Tena-Sempere M, Aguilar R, Blanco A. Biological role of pituitary estrogen receptors ERalpha and ERbeta on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat. Neuroendocrinology 2004, 79: 247–58.
Balen AH, Er J, Rafferty B, Rose M. In vitro bioactivity of gonadotrophin surge attenuating factor is not affected by an antibody to human inhibin. J Reprod Fertil 1995, 104: 285–9.
Ishigame H, Medan MS, Watanabe G, et al. A new alternative method for superovulation using passive immunization against inhibin in adult rats. Biol Reprod 2004, 71: 236–43.
Fink G. The self-priming effect of LHRH: A unique servomechanism and possible cellular model for memory. Front Neuroendocrinol 1995, 16: 183–90.
Turgeon JL, Waring DW. Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway. Mol Endocrinol 1994, 8: 860–9.
Turgeon JL, Waring DW. Rapid augmentation by progesterone of agonist-stimulated luteinizing hormone secretion by cultured pituitary cells. Endocrinology 1990, 127: 773–80.
Szabo M, Kilen SM, Nho SJ, Schwartz NB. Progesterone receptor A and B messenger ribonucleic acid levels in the anterior pituitary of rats are regulated by estrogen. Biol Reprod 2000, 62: 95–102.
Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women. Hum Reprod 1996, 11: 2585–90.
Messinis IE. Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod Update 2006, 12: 557–71.
Fox SR, Harlan RE, Shivers BD, Pfaff DW. Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neuroendocrinology 1990, 51: 276–83.
Lange CA, Shen T, Horwitz KB. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 2000, 97: 1032–7.
Bellido C, Gonzalez D, Aguilar R, Sanchez-Criado JE. Antiprogestins RU486 and ZK299 suppress basal and lhrh-stimulated fsh and lh secretion at pituitary level in the rat in an oestrous cycle stage-dependent manner. J Endocrinol 1999, 163: 79–85.
Sánchez-Criado JE, Ruiz A, Tébar M, Mattheij JA. Follicular and luteal progesterone synergize to maintain 5-day cyclicity in rats. Rev Esp Fisiol 1996, 52: 223–9.
Schuiling GA, Valkhof N, Koiter TR. FSH inhibits the augmentation by oestradiol of the pituitary responsiveness to GnRH in the female rat. Hum Reprod 1999, 14: 21–6.
Mattheij JA, Swarts JJ, van der Heijden AJ, van Helvoort AL, Kusters IC. Advancement of meiotic resumption in graafian follicles reduces fertility in the rat. Gynecol Obstet Invest 1993, 36: 129–35.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gordon, A., Aguilar, R., Garrido-Gracia, J.C. et al. Human follicular fluid from superovulated women inhibits progesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat. J Endocrinol Invest 33, 564–570 (2010). https://doi.org/10.1007/BF03346649
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346649